It looks like you are coming from United States, but the current site you have selected to visit is Kenya. Do you want to change site?
"Our growth in revenue and operating earnings in the first quarter is a
testament to the strength of our comprehensive water portfolio,
particularly the investments we’ve made in expanding our analytics and
dewatering platforms,” said
“We continue to see strong growth in our businesses serving the
industrial markets, our largest end market,” McClain continued. “We are
gaining market share in commercial building services, bolstered by some
of our new products including the energy-saving eSV multistage booster
pump. Total orders for the quarter exceeded
Xylem achieved free cash flow of
First Quarter Segment Results
Water Infrastructure
Xylem’s Water Infrastructure businesses provide equipment and services focused on the transport, treatment and testing of water and wastewater in the public utility and industrial markets.
Applied Water
Xylem’s Applied Water businesses provide equipment and services in the residential and commercial building services, general industrial and agricultural markets.
Affirming previous full-year 2012 guidance
Xylem is affirming previous guidance for full-year 2012 revenue in the
range of
More detail available
Supplemental information on Xylem’s first quarter earnings, including reconciliations for certain non-GAAP items, is posted at investors.xyleminc.com.
About Xylem
Xylem (XYL) is a leading global water technology provider, enabling
customers to transport, treat, test and efficiently use water in public
utility, residential and commercial building services, industrial and
agricultural settings. The company does business in more than 150
countries through a number of market-leading product brands, and its
people bring broad applications expertise with a strong focus on finding
local solutions to the world’s most challenging water and wastewater
problems. Launched in 2011 from the spinoff of the water-related
businesses of
The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all -- that which occurs in nature. For more information, please visit us at www.xyleminc.com.
Forward-Looking Statements
This document contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.
These forward-looking statements include, but are not limited to,
statements about the separation of
Caution should be taken not to place undue reliance on any such
forward-looking statements because they involve risks, uncertainties and
other factors that could cause actual results to differ materially from
those expressed or implied in, or reasonably inferred from, such
statements. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by law. In
addition, forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
the Company’s historical experience and our present expectations or
projections. These risks and uncertainties include, but are not limited
to, those set forth in Item 1A in our Annual Report on Form 10-K, and
those described from time to time in subsequent reports filed with the
*The 2011 normalized earnings per share reflect adjustments (including interest expense, stand-alone costs, and special tax items) to our GAAP results to better illustrate year-over-year performance. The normalized earnings are intended to give a representation of our performance had Xylem been a stand-alone company in 2011.
XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED AND COMBINED INCOME STATEMENTS (Unaudited) (in millions, except per share data) |
||||||||||||
For the three months ended March 31, | 2012 | 2011 | ||||||||||
Revenue | $ | 925 | $ | 890 | ||||||||
Cost of revenue | 562 | 553 | ||||||||||
Gross profit | 363 | 337 | ||||||||||
Selling, general and administrative expenses | 231 | 210 | ||||||||||
Research and development expenses | 28 | 24 | ||||||||||
Separation costs | 5 | 3 | ||||||||||
Operating income | 99 | 100 | ||||||||||
Interest expense | 14 | ─ | ||||||||||
Other non-operating (expense) income, net | (1 | ) | 1 | |||||||||
Income before taxes | 84 | 101 | ||||||||||
Income tax expense | 21 | 23 | ||||||||||
Net income | $ | 63 | $ | 78 | ||||||||
Earnings per share: | ||||||||||||
Basic | $ | 0.34 | $ | 0.42 | ||||||||
Diluted | $ | 0.34 | $ | 0.42 | ||||||||
Weighted average number of shares – Basic | 185.4 | 184.6 | ||||||||||
Weighted average number of shares – Diluted | 185.9 | 184.6 | ||||||||||
Dividends declared per share | $ | 0.1012 | $ ─ | |||||||||
XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (in millions) |
|||||||||||
For the three months ended March 31, | 2012 | 2011 | |||||||||
Net income | $ | 63 | $ | 78 | |||||||
Other comprehensive income, before tax: | |||||||||||
Foreign currency translation adjustment | 49 | 86 | |||||||||
Net change in cash flow hedges: | |||||||||||
Unrealized gains (losses) | 4 | ─ | |||||||||
Net change in postretirement benefit plans: | |||||||||||
Amortization of net actuarial loss | 2 | ─ | |||||||||
Settlement | 2 | ─ | |||||||||
Other comprehensive income, before tax | 57 | 86 | |||||||||
Income tax expense related to items of other comprehensive income | 2 | ─ | |||||||||
Other comprehensive income, net of tax | 55 | 86 | |||||||||
Comprehensive income | $ | 118 | $ | 164 | |||||||
XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (in millions, except per share amounts) |
||||||||||||
March 31, |
|
December 31, | ||||||||||
2012 | 2011 | |||||||||||
(Unaudited) | ||||||||||||
ASSETS | ||||||||||||
Current assets: | ||||||||||||
Cash and cash equivalents | $ | 347 | $ | 318 | ||||||||
Receivables, less allowances for discounts and doubtful accounts of $32 and $37 in 2012 and 2011, respectively |
761 |
756 |
||||||||||
Inventories, net | 465 | 426 | ||||||||||
Prepaid and other current assets | 117 | 97 | ||||||||||
Deferred income tax assets | 45 | 45 | ||||||||||
Total current assets | 1,735 | 1,642 | ||||||||||
Property, plant and equipment, net | 468 | 463 | ||||||||||
Goodwill | 1,631 | 1,610 | ||||||||||
Other intangible assets, net | 502 | 505 | ||||||||||
Other non-current assets | 177 | 173 | ||||||||||
Total assets | $ | 4,513 | $ | 4,393 | ||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||
Current liabilities: | ||||||||||||
Accounts payable | $ | 329 | $ | 322 | ||||||||
Accrued and other current liabilities | 486 | 490 | ||||||||||
Short-term borrowings and current maturities of long-term debt | 4 | 5 | ||||||||||
Total current liabilities | 819 | 817 | ||||||||||
Long-term debt | 1,202 | 1,201 | ||||||||||
Accrued postretirement benefits | 320 | 316 | ||||||||||
Deferred income tax liability | 155 | 165 | ||||||||||
Other non-current accrued liabilities | 68 | 67 | ||||||||||
Total liabilities | 2,564 | 2,566 | ||||||||||
Commitments and contingencies (Note 14)
Stockholders’ equity: |
||||||||||||
Common Stock – authorized 750.0 shares, par value $0.01 per share: | ||||||||||||
Issued 185.4 shares and 184.6 shares in 2012 and 2011, respectively | 2 | 2 | ||||||||||
Capital in excess of par value | 1,687 | 1,663 | ||||||||||
Retained earnings | 84 | 40 | ||||||||||
Treasury stock – at cost 0.1 shares and 0 shares in 2012 and 2011, respectively | (1 | ) | ─ | |||||||||
Accumulated other comprehensive income | 177 | 122 | ||||||||||
Total stockholders’ equity | 1,949 | 1,827 | ||||||||||
Total liabilities and stockholders’ equity | $ | 4,513 | $ | 4,393 | ||||||||
XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS (Unaudited) (in millions) |
|||||||||||||
For the three months ended March 31, | 2012 | 2011 | |||||||||||
Operating Activities | |||||||||||||
Net income | $ | 63 | $ | 78 | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||||||||
Depreciation and amortization | 34 | 33 | |||||||||||
Share-based compensation | 5 | 3 | |||||||||||
Payments of restructuring | — | (5 | ) | ||||||||||
Changes in assets and liabilities (net of acquisitions): | |||||||||||||
Changes in receivables | 7 | (3 | ) | ||||||||||
Changes in inventories | (31 | ) | (16 | ) | |||||||||
Changes in accounts payable | 14 | (31 | ) | ||||||||||
Changes in accrued liabilities | (25 | ) | (5 | ) | |||||||||
Changes in accrued taxes | 3 | 11 | |||||||||||
Net changes in other assets and liabilities | (9 | ) | 6 | ||||||||||
Net Cash - Operating activities | 61 | 71 | |||||||||||
Investing Activities | |||||||||||||
Capital expenditures | (31 | ) | (19 | ) | |||||||||
Proceeds from the sale of property, plant and equipment | 2 | 2 | |||||||||||
Other, net | — | (1 | ) | ||||||||||
Net Cash - Investing activities | (29 | ) | (18 | ) | |||||||||
Financing Activities | |||||||||||||
Net transfer (to)/from former parent | (6 | ) | (33 | ) | |||||||||
Issuance of short-term debt | 3 | — | |||||||||||
Principal payments of debt and capital lease obligations | (3 | ) | — | ||||||||||
Purchase of common stock | (1 | ) | — | ||||||||||
Proceeds from exercise of employee stock options | 16 | — | |||||||||||
Tax impact from equity compensation activity | (1 | ) | — | ||||||||||
Dividends paid | (19 | ) | — | ||||||||||
Other, net | 1 | — | |||||||||||
Net Cash - Financing activities | (10 | ) | (33 | ) | |||||||||
Effect of exchange rate changes on cash | 7 | 3 | |||||||||||
Net change in cash and cash equivalents | 29 | 23 | |||||||||||
Cash and cash equivalents at beginning of year | 318 | 131 | |||||||||||
Cash and cash equivalents at end of year | $ | 347 | $ | 154 | |||||||||
Supplemental disclosure of cash flow information: Cash paid during the period for: |
|||||||||||||
Interest | $ | 11 | $ | — | |||||||||
Income taxes (net of refunds received) | $ | 18 | $ | 9 | |||||||||
Xylem Inc. Non-GAAP Measures |
Management views key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenues, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators: |
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of foreign currency fluctuations, intercompany transactions, and contributions from acquisitions and divestitures. Divestitures include sales of portions of our business that did not meet the criteria for classification as a discontinued operation or insignificant portions of our business that we did not classify as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period. |
“Constant currency” defined as financial results adjusted for currency by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries where the functional currency is the local currency. |
“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude for one-time separation costs associated with the Xylem spin-off from ITT Corporation. |
“Operating Income * ” and “Adjusted EPS” defined as operating income and earnings per share, adjusted to exclude one-time separation costs associated with the Xylem spin-off from ITT Corporation and tax-related special items. |
“Normalized EPS” defined as earnings per share, adjusted to exclude one-time separation costs associated with the Xylem spin-off from ITT Corporation and tax-related special items, as well as an adjustment to reflect the incremental current period amount of interest expense and stand-alone costs in the prior comparable period. |
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider non-discretionary cash payments, such as debt. |
Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||||||||||||||||||
Reported vs. Organic & Constant Currency Revenue / Order Growth | ||||||||||||||||||||||||||||||
($ Millions) | ||||||||||||||||||||||||||||||
(As reported - GAAP) | (As Adjusted - Organic) | Constant Currency | ||||||||||||||||||||||||||||
(A) | (B) | (C) | (D) | (E) | (F) = B+C+D+E | (G) = F/A | (H) = (B + D) / A | |||||||||||||||||||||||
Orders |
||||||||||||||||||||||||||||||
Change | % Change |
Acquisitions/ |
Change | % Change | ||||||||||||||||||||||||||
Orders | Orders | 2012 v. 2011 | 2012 v. 2011 |
Divestitures |
FX Contribution | Eliminations | Adj. 2012 v. 2011 | Adj. 2012 v. 2011 | ||||||||||||||||||||||
2012 | 2011 | |||||||||||||||||||||||||||||
Quarter Ended March 31, 2012 |
||||||||||||||||||||||||||||||
Xylem Inc. | 1,004 | 978 | 26 | 2.7% | (37) | 18 | - | 7 | 0.7% | 4.5% | ||||||||||||||||||||
Water infrastructure | 638 | 612 | 26 | 4.2% | (37) | 13 | - | 2 | 0.3% | 6.4% | ||||||||||||||||||||
Applied Water | 382 | 381 | 1 | 0.3% | - | 5 | (1) | 5 | 1.3% | 1.6% | ||||||||||||||||||||
Revenue |
||||||||||||||||||||||||||||||
Change | % Change |
Acquisitions/ |
Change | % Change | ||||||||||||||||||||||||||
Revenue | Revenue | 2012 v. 2011 | 2012 v. 2011 |
Divestitures |
FX Contribution | Eliminations | Adj. 2012 v. 2011 | Adj. 2012 v. 2011 | ||||||||||||||||||||||
2012 | 2011 | |||||||||||||||||||||||||||||
Quarter Ended March 31, 2012 |
||||||||||||||||||||||||||||||
Xylem Inc. | 925 | 890 | 35 | 3.9% | (34) | 14 | - | 15 | 1.7% | 5.5% | ||||||||||||||||||||
Water infrastructure | 584 | 551 | 33 | 6.0% | (34) | 10 | 1 | 10 | 1.8% | 7.8% | ||||||||||||||||||||
Applied Water | 355 | 355 | - | 0.0% | - | 5 | - | 5 | 1.4% | 1.4% | ||||||||||||||||||||
Note: Due to rounding and intersegment eliminations the sum of segment amounts may not agree to Xylem totals. | ||||||||||||||||||||||||||||||
Xylem Inc. Non-GAAP Reconciliation | ||||||||||
Adjusted Diluted EPS | ||||||||||
For The Three Months Ended 2012 & 2011 | ||||||||||
($ Millions, except per share amounts) | ||||||||||
Q1 2012 | Q1 2011 | |||||||||
Net Income | 63 | 78 | ||||||||
Separation costs, net of tax | 4 | 2 | ||||||||
Adjusted Net Income before Special Tax Items | 67 | 80 | ||||||||
Special Tax Items | - | - | ||||||||
Adjusted Net Income | 67 | 80 | ||||||||
Diluted Earnings per Share | $0.34 | $0.42 | ||||||||
Separation costs per Share | $0.02 | $0.01 | ||||||||
Adjusted diluted EPS before Special Tax Items | $0.36 | $0.43 | ||||||||
Special Tax Items per Share | $0.00 | $0.00 | ||||||||
Adjusted diluted EPS | $0.36 | $0.43 | ||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||||||||||||||||||||||||||||||||||
Normalized and Adjusted Diluted EPS | |||||||||||||||||||||||||||||||||||||||||||||||||
($ Millions, except per share amounts) | |||||||||||||||||||||||||||||||||||||||||||||||||
Q1 2011 | Q1 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||
As Reported | Adjustments | Adjusted | Adjustments | Normalized | As Reported | Adjustments | Adjusted | ||||||||||||||||||||||||||||||||||||||||||
Total Revenue | 890 | 890 | 890 | 925 | 925 | ||||||||||||||||||||||||||||||||||||||||||||
Operating Income | 100 | 3 | a | 103 | (10 | ) | c | 93 | 99 | 5 | a | 104 | |||||||||||||||||||||||||||||||||||||
Operating Margin | 11.2 | % | 11.6 | % | 10.4 | % | 10.7 | % | 11.2 | % | |||||||||||||||||||||||||||||||||||||||
Interest Expense | - | - | (13 | ) | d | (13 | ) | (14 | ) | (14 | ) | ||||||||||||||||||||||||||||||||||||||
Other Non-Operating Income (Expense) | 1 | 1 | 1 | (1 | ) | (1 | ) | ||||||||||||||||||||||||||||||||||||||||||
Income before Taxes | 101 | 3 | 104 | (23 | ) | 81 | 84 | 5 | 89 | ||||||||||||||||||||||||||||||||||||||||
Provision for Income Taxes | (23 | ) | (1 | ) | b | (24 | ) | 5 | e | (19 | ) | (21 | ) | (1 | ) | b | (22 | ) | |||||||||||||||||||||||||||||||
Net Income | 78 | 2 | 80 | (18 | ) | 62 | 63 | 4 | 67 | ||||||||||||||||||||||||||||||||||||||||
Diluted Shares | 184.6 | 184.6 | 185.9 | 185.9 | |||||||||||||||||||||||||||||||||||||||||||||
Diluted EPS | $ | 0.42 | $ | 0.01 | $ | 0.43 | $ | (0.10 | ) | $ | 0.33 | $ | 0.34 | $ | 0.02 | $ | 0.36 | ||||||||||||||||||||||||||||||||
a One time separation costs |
|||||||||||||||||||||||||||||||||||||||||||||||||
b Tax impact of one time separation costs |
|||||||||||||||||||||||||||||||||||||||||||||||||
c Incremental stand alone costs incurred in 2012 |
|||||||||||||||||||||||||||||||||||||||||||||||||
d Incremental interest expense on long-term debt incurred in 2012 |
|||||||||||||||||||||||||||||||||||||||||||||||||
e Tax impact of incremental interest expense and stand alone costs incurred in 2012 |
|||||||||||||||||||||||||||||||||||||||||||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||||||||||||
Segment Operating Income | |||||||||||||||||||||||||||
($ Millions) | |||||||||||||||||||||||||||
Adjusted Segment Operating Income | |||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | ||||||||||||||||||||||||
'12 |
'11 |
'12 |
'11 |
'12 |
'11 |
'12 |
'11 |
||||||||||||||||||||
Total Revenue | |||||||||||||||||||||||||||
• Water Infrastructue | 584 | 551 | - | 602 | - | 584 | - | 679 | |||||||||||||||||||
• Applied Water | 355 | 355 | - | 385 | - | 368 | - | 336 | |||||||||||||||||||
Operating Income | |||||||||||||||||||||||||||
• Water Infrastructue | 75 | 64 | - | 94 | - | 87 | - | 98 | |||||||||||||||||||
• Applied Water | 40 | 46 | - | 50 | - | 37 | - | 27 | |||||||||||||||||||
Separation Costs | |||||||||||||||||||||||||||
• Water Infrastructue | 2 | - | - | 2 | - | 8 | - | 6 | |||||||||||||||||||
• Applied Water | 1 | - | - | - | - | 9 | - | 4 | |||||||||||||||||||
Adjusted Operating Income* | |||||||||||||||||||||||||||
• Water Infrastructue | 77 | 64 | - | 96 | - | 95 | - | 104 | |||||||||||||||||||
• Applied Water | 41 | 46 | - | 50 | - | 46 | - | 31 | |||||||||||||||||||
Operating Margin | |||||||||||||||||||||||||||
• Water Infrastructue | 12.8% | 11.6% | 15.6% | 14.9% | 14.4% | ||||||||||||||||||||||
• Applied Water | 11.3% | 13.0% | 13.0% | 10.0% | 8.0% | ||||||||||||||||||||||
Adjusted Operating Margin* | |||||||||||||||||||||||||||
• Water Infrastructue | 13.2% | 11.6% | 15.9% | 16.3% | 15.3% | ||||||||||||||||||||||
• Applied Water | 11.5% | 13.0% | 13.0% | 12.5% | 9.2% | ||||||||||||||||||||||
*Adjusted Operating Income excludes non-recurring separation costs | |||||||||||||||||||||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||
Net Cash - Operating Activities vs. Free Cash Flow | |||||||||
For The Three Months Ended 2012 & 2011 | |||||||||
($ Millions) | |||||||||
Three Months Ended | |||||||||
2012 | 2011 | ||||||||
Net Cash - Operating Activities | 61 | 71 | |||||||
Capital Expenditures | (31) | (19) | |||||||
Free Cash Flow, including separation costs | 30 | 52 | |||||||
Separation Costs (Cash Paid incl. Capex) | 11 | 2 | |||||||
Free Cash Flow, excluding separation costs | 41 | 54 | |||||||
Net Income | 63 | 78 | |||||||
Separation Costs, net of tax | 4 | 2 | |||||||
Adjusted Net Income | 67 | 80 | |||||||
Free Cash Flow Conversion | 61% | 68% | |||||||
Source:
Xylem Inc.
Media
Tom Glover, +1-914-323-5891
Tom.Glover@xyleminc.com
or
Investors
Phil
De Sousa, +1-914-323-5930
Phil.DeSousa@xyleminc.com
Xylem